<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Gianluca Gaïdano, Davide Rossi et al.|Haematologica|2019Cited by 137
Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemiaFary Diop, Gianluca Gaïdano, Elisa Spaccarotella et al.|Haematologica|2019Cited by 87
Precision Medicine Management of Chronic Lymphocytic LeukemiaRiccardo Moia, Gianluca Gaïdano, Andrea Patriarca et al.|Cancers|2020Cited by 38
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Riccardo Moia, Donatella Talotta et al.|British Journal of Haematology|2022Cited by 24
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutationsSara Raponi, Robin Foà, Caterina Ilari et al.|British Journal of Haematology|2020Cited by 23